US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist

0.3400
+0.0098+2.97%

Close Aug 23 16:00 ET

0.3401
+0.0001+0.03%

Post 20:01 ET

7.48MMarket Cap-22P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

57.55%-9.92M

46.60%-17.58M

-4.03%-102M

-0.17%-22.34M

0.64%-23.39M

-10.37%-23.37M

-6.01%-32.91M

-29.77%-98.05M

0.64%-22.3M

-81.79%-23.54M

Net income from continuing operations

-177.81%-78.78M

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

Operating gains losses

--855K

---7.01M

--221K

--417K

----

Depreciation and amortization

30.84%1.21M

35.50%1.21M

242.46%4.29M

50.84%1.26M

382.54%1.22M

802.94%921K

1,317.46%893K

2,406.00%1.25M

2,996.30%836K

2,420.00%252K

Other non cash items

--129K

--302K

--903K

----

Change In working capital

182.81%4.82M

132.42%1.17M

-1,650.00%-35K

-93.77%363K

-38.62%1.49M

280.13%1.7M

50.86%-3.59M

-100.03%-2K

21.78%5.83M

-25.72%2.43M

-Change in receivables

----

---1.56M

----

-Change in inventory

--1.16M

--1.29M

--61K

----

--0

----

-Change in prepaid assets

60.52%2.37M

-12.35%-1.36M

1,059.15%1.57M

-398.98%-1.76M

-15.49%3.07M

166.55%1.47M

44.32%-1.21M

-131.66%-164K

-66.05%589K

740.99%3.63M

-Change in payables and accrued expense

2,028.44%4.64M

151.64%1.23M

-1,165.00%-1.7M

-90.65%490K

97.50%-30K

-82.78%218K

53.70%-2.38M

-96.97%160K

71.78%5.24M

-131.39%-1.2M

-Change in other current liabilities

----

1,650.00%35K

466.67%11K

----

--2K

---3K

----

-Change in other working capital

-133.33%-4K

140.00%2K

----

300.00%12K

-400.00%-5K

----

Cash from discontinued investing activities

Operating cash flow

57.55%-9.92M

46.60%-17.58M

-4.03%-102M

-0.17%-22.34M

0.64%-23.39M

-10.37%-23.37M

-6.01%-32.91M

-29.77%-98.05M

0.64%-22.3M

-81.79%-23.54M

Investing cash flow

Cash flow from continuing investing activities

97.16%-108K

39.62%-29.07M

90.77%-431K

90.69%-821K

-66.35%-24.02M

81.21%-3.8M

-36.37%-48.15M

81.77%-4.67M

-13.79%-8.82M

Net PPE purchase and sale

--0

97.16%-108K

85.68%-6.9M

90.77%-431K

90.69%-821K

87.22%-1.85M

81.21%-3.8M

-36.37%-48.15M

81.77%-4.67M

-13.79%-8.82M

Net business purchase and sale

----

---22.17M

--0

----

--0

Cash from discontinued investing activities

Investing cash flow

--0

97.16%-108K

39.62%-29.07M

90.77%-431K

90.69%-821K

-66.35%-24.02M

81.21%-3.8M

-36.37%-48.15M

81.77%-4.67M

-13.79%-8.82M

Financing cash flow

Cash flow from continuing financing activities

582.70%7.03M

98.16%-212K

-58.43%36.52M

463.20%40.71M

235.65%6.27M

-98.57%1.03M

-188.03%-11.5M

-58.66%87.84M

-83.48%7.23M

-112.18%-4.63M

Net issuance payments of debt

---705K

---235K

--8.94M

----

--0

----

Net common stock issuance

942.76%10.73M

--0

-94.73%4.97M

-4.49%9.2M

-76.65%6.27M

-97.71%1.03M

-188.53%-11.53M

-55.52%94.46M

-77.99%9.63M

-29.08%26.88M

Net preferred stock issuance

----

--0

----

---6.66M

---2.4M

---31.5M

Proceeds from stock option exercised by employees

--0

-20.69%23K

-27.50%29K

--0

-27.50%29K

-59.18%40K

--0

Net other financing activities

----

--22.57M

----

Cash from discontinued financing activities

Financing cash flow

582.70%7.03M

98.16%-212K

-58.43%36.52M

463.20%40.71M

235.65%6.27M

-98.57%1.03M

-188.03%-11.5M

-58.66%87.84M

-83.48%7.23M

-112.18%-4.63M

Net cash flow

Beginning cash position

-88.99%7.95M

-78.54%25.85M

-32.66%120.47M

-94.35%7.92M

-85.41%25.86M

-48.66%72.22M

-32.66%120.47M

131.41%178.9M

-23.47%140.22M

6.78%177.22M

Current changes in cash

93.76%-2.89M

62.88%-17.9M

-62.03%-94.56M

190.88%17.94M

51.51%-17.93M

-226.77%-46.36M

-26.20%-48.21M

-157.42%-58.36M

-359.14%-19.74M

-314.20%-36.98M

Effect of exchange rate changes

--1K

90.70%-4K

12.16%-65K

-100.00%-10K

40.00%-12K

--0

-72.00%-43K

-138.71%-74K

50.00%-5K

-53.85%-20K

End cash Position

-80.44%5.06M

-88.99%7.95M

-78.54%25.85M

-94.35%7.92M

-85.41%25.86M

-48.66%72.22M

-32.66%120.47M

-23.47%140.22M

Free cash flow

60.66%-9.92M

51.83%-17.68M

24.83%-109.9M

15.55%-22.78M

22.12%-25.2M

29.20%-25.21M

28.39%-36.71M

-31.87%-146.2M

43.89%-26.97M

-56.33%-32.36M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	57.55%-9.92M	46.60%-17.58M	-4.03%-102M	-0.17%-22.34M	0.64%-23.39M	-10.37%-23.37M	-6.01%-32.91M	-29.77%-98.05M	0.64%-22.3M	-81.79%-23.54M
Net income from continuing operations	-177.81%-78.78M	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M
Operating gains losses	--855K	---7.01M	--221K	--417K	----	----	----	----	----	----
Depreciation and amortization	30.84%1.21M	35.50%1.21M	242.46%4.29M	50.84%1.26M	382.54%1.22M	802.94%921K	1,317.46%893K	2,406.00%1.25M	2,996.30%836K	2,420.00%252K
Other non cash items	--129K	--302K	--903K	----	----	----	----	----	----	----
Change In working capital	182.81%4.82M	132.42%1.17M	-1,650.00%-35K	-93.77%363K	-38.62%1.49M	280.13%1.7M	50.86%-3.59M	-100.03%-2K	21.78%5.83M	-25.72%2.43M
-Change in receivables	----	----	----	----	---1.56M	----	----	----	----	----
-Change in inventory	--1.16M	--1.29M	--61K	----	----	--0	--0	--0	----	----
-Change in prepaid assets	60.52%2.37M	-12.35%-1.36M	1,059.15%1.57M	-398.98%-1.76M	-15.49%3.07M	166.55%1.47M	44.32%-1.21M	-131.66%-164K	-66.05%589K	740.99%3.63M
-Change in payables and accrued expense	2,028.44%4.64M	151.64%1.23M	-1,165.00%-1.7M	-90.65%490K	97.50%-30K	-82.78%218K	53.70%-2.38M	-96.97%160K	71.78%5.24M	-131.39%-1.2M
-Change in other current liabilities	----	----	1,650.00%35K	466.67%11K	----	----	----	--2K	---3K	----
-Change in other working capital	-133.33%-4K	140.00%2K	----	----	----	300.00%12K	-400.00%-5K	----	----	----
Cash from discontinued investing activities
Operating cash flow	57.55%-9.92M	46.60%-17.58M	-4.03%-102M	-0.17%-22.34M	0.64%-23.39M	-10.37%-23.37M	-6.01%-32.91M	-29.77%-98.05M	0.64%-22.3M	-81.79%-23.54M
Investing cash flow
Cash flow from continuing investing activities	0	97.16%-108K	39.62%-29.07M	90.77%-431K	90.69%-821K	-66.35%-24.02M	81.21%-3.8M	-36.37%-48.15M	81.77%-4.67M	-13.79%-8.82M
Net PPE purchase and sale	--0	97.16%-108K	85.68%-6.9M	90.77%-431K	90.69%-821K	87.22%-1.85M	81.21%-3.8M	-36.37%-48.15M	81.77%-4.67M	-13.79%-8.82M
Net business purchase and sale	----	----	---22.17M	--0	--0	----	----	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	97.16%-108K	39.62%-29.07M	90.77%-431K	90.69%-821K	-66.35%-24.02M	81.21%-3.8M	-36.37%-48.15M	81.77%-4.67M	-13.79%-8.82M
Financing cash flow
Cash flow from continuing financing activities	582.70%7.03M	98.16%-212K	-58.43%36.52M	463.20%40.71M	235.65%6.27M	-98.57%1.03M	-188.03%-11.5M	-58.66%87.84M	-83.48%7.23M	-112.18%-4.63M
Net issuance payments of debt	---705K	---235K	--8.94M	----	----	--0	--0	--0	----	----
Net common stock issuance	942.76%10.73M	--0	-94.73%4.97M	-4.49%9.2M	-76.65%6.27M	-97.71%1.03M	-188.53%-11.53M	-55.52%94.46M	-77.99%9.63M	-29.08%26.88M
Net preferred stock issuance	----	----	--0	--0	----	----	----	---6.66M	---2.4M	---31.5M
Proceeds from stock option exercised by employees	--0	-20.69%23K	-27.50%29K	--0	--0	--0	-27.50%29K	-59.18%40K	--0	--0
Net other financing activities	----	----	--22.57M	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	582.70%7.03M	98.16%-212K	-58.43%36.52M	463.20%40.71M	235.65%6.27M	-98.57%1.03M	-188.03%-11.5M	-58.66%87.84M	-83.48%7.23M	-112.18%-4.63M
Net cash flow
Beginning cash position	-88.99%7.95M	-78.54%25.85M	-32.66%120.47M	-94.35%7.92M	-85.41%25.86M	-48.66%72.22M	-32.66%120.47M	131.41%178.9M	-23.47%140.22M	6.78%177.22M
Current changes in cash	93.76%-2.89M	62.88%-17.9M	-62.03%-94.56M	190.88%17.94M	51.51%-17.93M	-226.77%-46.36M	-26.20%-48.21M	-157.42%-58.36M	-359.14%-19.74M	-314.20%-36.98M
Effect of exchange rate changes	--1K	90.70%-4K	12.16%-65K	-100.00%-10K	40.00%-12K	--0	-72.00%-43K	-138.71%-74K	50.00%-5K	-53.85%-20K
End cash Position	-80.44%5.06M	-88.99%7.95M	-78.54%25.85M	-78.54%25.85M	-94.35%7.92M	-85.41%25.86M	-48.66%72.22M	-32.66%120.47M	-32.66%120.47M	-23.47%140.22M
Free cash flow	60.66%-9.92M	51.83%-17.68M	24.83%-109.9M	15.55%-22.78M	22.12%-25.2M	29.20%-25.21M	28.39%-36.71M	-31.87%-146.2M	43.89%-26.97M	-56.33%-32.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall